Wednesday, 13 September 2023

Healthcare stocks surge; Moderna anticipates $10-15B annual sales boost by 2028

This new A.I. tech is a retirement game changer

A brand-new A.I. algorithm recently came onto the scene that can predict stock prices one month into the future with astonishing accuracy. Imagine if you had this kind of predictive power. It could be a complete retirement game changer. You can now get the full story and to see what this algorithm is saying the price of AAPL, NVDA, TSLA will be one month from now.

Click Here [ad]
Free ebook: Reveal Key Stock Market Secrets

Learn the 6 greatest stock market myths – 3 rules to pick the right stocks – Powerful techniques to accurately value stocks – Insights on stock valuation and stock market cycles – Secrets revealed on how to successfully manage your portfolio and much more…

Download Your Free eBook [ad]
See What One Ticker... One Trade... EVERY WEEK...Can Do for YOU

New research proves that trading one ticker every week has had the ability to produce extraordinary gains...

Including a rare 2,614% in under 11 days.

See this groundbreaking new discovery for yourself.

Show me one ticker payouts.
 [ad]

UBS upgraded General Motors to a Buy rating (From Neutral) and raised their 12-month price target on the auto stock to $44.00 (From $41.00). This upgrade is grounded in GM's consistent performance amidst a highly uncertain and volatile economic landscape, notably maintaining an 8-10% GM North America (GMNA) EBIT-Adjusted margin.


Moderna (NASDAQ:MRNA) experienced a significant increase in value, gaining over 6% after announcing its expectation to add $10 billion to $15 billion in annual sales by 2028. This anticipated surge is tied to the introduction of new products targeting oncology, as well as rare and latent diseases.






DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.








2563 cherry hill ln, Hermitage, PA 16148, United States
You may unsubscribe or change your contact details at any time.

No comments:

Post a Comment

7 Stocks That Will Lead the Post-Election Rally Into 2025

Stocks have been on a tear since investors got a swift and decisive resolution to the U.S. presidential election. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ...